Although Invokana was approved by the United States Food and Drug Administration at the end of March in 2013 it associated with several life threatening complications, the FDA has issued a follow-up side effect warning in May of 2016 to inform patients and doctors about the health risks linked with Invokana medication. The complications includes Diabetic Ketoacidosis (DKA), Kidney Injury, and of amputation of leg, foot, or toes. Other studies have raised concerns about cardiovascular injuries, such as heart attack or stroke. As per the new investigation performed by the FDA the SGLT2 inhibitor Type 2 diabetes medications are associated with Acute Pancreatitis. According to the agency they have revised the warnings in the drug labels to include information about the severe risk cause by the medicine and added recommendations to minimize this risk.
Invokana (canagliflozin) is one of several “new generation” type 2 diabetes drugs known as SGLT2 inhibitors approved on March 29, 2013 by U.S Food and Drugs Administration. The drug inhibits normal kidney function to allow patients to pass excess blood glucose through urination. It is manufactured by Janssen Pharmaceuticals, a division of Johnson & Johnson. Janssen also markets Invokamet, a combination of canagliflozin and metformin. Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals, are facing thousands of Invokana lawsuits due to serious injury caused by Invokana. The plaintiff’s claims that manufacturers failed to provide adequate warnings and communications to the medical community and end line consumers of the increased risk of serious and life threatening medical complications associated with these drug.
According to the plaintiffs the manufacturers knew that the drug could cause severe health issues however they were reckless in releasing the drug to market without testing the drug properly. Plaintiffs claim that if the company had warned of the risks, then patients would have been prescribed with the other drugs like metformin which is the first-choice treatment for patients with type 2 diabetes in compare with the other diabetic Drugs. Johnson & Johnson paying tens of millions of dollars in marketing the products for medical consultants, literally wining and dining, despite of giving kickback to the doctors to prescribe their medicine the manufactures have to break their silence and reveal the risk linked with Invokana. Instead of more clinical trials Johnson and Johnson paid millions of dollars for advertisements and putting thousands of life at risk.
People taking canagliflozin are urged to monitor their health closely and discuss with their doctor about the benefits and risks of the drug. If you or someone you love who was prescribed Invokana and then suffered from ketoacidosis, kidney failure, Heart Attack or Stroke may be eligible to file a personal injury lawsuit against the drug’s manufacturer. The Drugsclaim Lawyers and Attorneys are investigating claims that Invokana may be linked to kidney failure, cardiovascular complications and bone fractures. In filing personal injury lawsuits, injured patients seek compensation for medical expenses, lost work and pain and suffering, among other damages.